Nasdaq
IBRX
ImmunityBio, Inc.
- Health Care
- Listed 2015
- 1 day
- +1.0%
- 1 month
- −16.4%
- 1 year
- +208%
$7.32 · Mkt cap $7.76B
At the 6 Aug 2026 close
Nasdaq
ImmunityBio, Inc.
$7.32 · Mkt cap $7.76B
At the 6 Aug 2026 close
ImmunityBio, Inc. trades under the ticker IBRX on Nasdaq, in the Health Care sector (Biotechnology: Biological Products (No Diagnostic Substances)). It has been listed since 2015. Its market capitalisation is $7.76B. The last closing price was $7.32, on 6 Aug 2026. No price-to-earnings ratio is shown, because it did not report positive earnings in its last annual filing. Over the past year the share price is +208%, and −16.4% over the past month. Returns are price returns and exclude dividends.
This page exists because IBRX is one of the shares What A Share can show you. It is not a recommendation, and its appearance here says nothing about whether the company is worth owning.